Gdf15 impairs progression of non-alcoholic fatty liver disease in obese mice by enhancing fatty acids oxidation [68, 69] and its deficiency promotes high fat diet-induced obesity [70] and exacerbates liver injury induced by chronic alcohol and carbon tetrachloride exposure [71]. Here, GDF15 is linked to metabolic dysfunction-associated steatotic liver disease.